Mast Therapeutics Inc (MSTX.A)
MSTX.A on American Stock Exchange
0.44USD
10:50am EDT
0.44USD
10:50am EDT
Price Change (% chg)
$-0.00 (-0.90%)
$-0.00 (-0.90%)
Prev Close
$0.44
$0.44
Open
$0.45
$0.45
Day's High
$0.46
$0.46
Day's Low
$0.43
$0.43
Volume
62,057
62,057
Avg. Vol
80,935
80,935
52-wk High
$0.87
$0.87
52-wk Low
$0.41
$0.41
About
Mast Therapeutics, Inc., formerly ADVENTRX Pharmaceuticals, Inc., is a development-stage company biopharmaceutical company focused on developing product candidates. The Company's product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves microvascular blood flow and has application in... (more)
Overall
| Beta: | 1.34 |
| Market Cap (Mil.): | $44.18 |
| Shares Outstanding (Mil.): | 96.27 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| MSTX.A | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.36 | -- | -- |
| ROI: | -35.87 | -2.58 | 18.76 |
| ROE: | -37.96 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $29.06 | -0.17 |
| Johnson & Johnson (JNJ.N) | $93.90 | +0.40 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Sanofi SA (SASY.PA) | €76.85 | -3.32 |
| GlaxoSmithKline plc (GSK.L) | 1,712.50p | +28.50 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

